Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Watch now and learn if GLP-1 treatment might be right for you
REDEFINE-1: Phase 3 Pivotal Trial (NCT05064293) Study Title: "Efficacy and Safety of CagriSema in Adults With Overweight or Obesity (REDEFINE 1)" Status: Completed (Results Published 2024) Phase: Phase 3 Enrollment: 3,400+ participants Study Period: 2021-2024 Location: Global, 15+ countries Design: Randomized, double-blind, active-controlled Duration: 68 weeks Intervention: CagriSema (cagrilintide 2.4mg + semaglutide 2.4mg) vs
[1] [2] These medications work by mimicking the action of naturally occurring GLP-1 hormone, which stimulates insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and promotes satiety
Rustici, G
While The First State offers many inpatient programs and local resources like Narcotics Anonymous chapters, many residents continue to succumb to the crisis
Obesity has become a global concern associated with severe health concerns such as heart disease and diabetes
US$ 22.85
US$ 29.37
US$ 27.47
US$ 20.17
US$ 29.86
